Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Taxotere, Doxorubicin and Cyclophosphamide (TAC) Primary Therapy in Stage III Breast Cancer

NCT00004175 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00004175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Taxotere, Doxorubicin and Cyclophosphamide (TAC) Primary Therapy in Stage III Breast Cancer
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1998
Completion date
June 30, 2005
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer